Bioactive Lipids as Chronic Myeloid Leukemia’s Potential Biomarkers for Disease Progression and Response to Tyrosine Kinase Inhibitors

Chronic myelogenous leukemia (CML) is a myeloproliferative neoplasm that expresses the Philadelphia chromosome and constitutively activated Bcr-Abl tyrosine kinase in hematopoietic progenitor cells. Bcr-Abl tyrosine-kinase inhibitors (TKI) do not definitively cure all CML patients. The efficacy of T...

Descripción completa

Detalles Bibliográficos
Autores principales: de Almeida, Felipe Campos, Berzoti-Coelho, Maria G., Toro, Diana Mota, Cacemiro, Maira da Costa, Bassan, Vitor Leonardo, Barretto, Gabriel Dessotti, Garibaldi, Pedro Manoel Marques, Palma, Leonardo Carvalho, de Figueiredo-Pontes, Lorena Lobo, Sorgi, Carlos Arterio, Faciolli, Lucia Helena, Gardinassi, Luiz Gustavo, de Castro, Fabíola Attié
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043757/
https://www.ncbi.nlm.nih.gov/pubmed/35493444
http://dx.doi.org/10.3389/fimmu.2022.840173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043757/
https://www.ncbi.nlm.nih.gov/pubmed/35493444
http://dx.doi.org/10.3389/fimmu.2022.840173

Ejemplares similares